MPI – Summary of Extraordinary General Meeting

Hoersholm; Denmark February 9, 2016 – Today at 4 p.m., an extraordinary general meeting was convened in Medical Prognosis Institute A/S with the following agenda:

  1. Resolution on the transfer of the Company’s admittance to trading on Nasdaq First North Denmark to Nasdaq First North Sweden
  2. Any other business

In accordance with article 11.2 of the Company’s articles of association, the board of directors had appointed Attorney-at-Law Thomas Holst Laursen to chair the general meeting.

Re item 1
The general meeting adopted the proposals of the board of directors.

Re item 2
There were no proposals for discussion under this item.

The board of directors of Medical Prognosis Institute A/S
Venlighedsvej 1, 2970 Hoersholm
Telephone: +45 22 93 08 37/+45 40 14 50 59

For further information, please contact

Peter Buhl Jensen, CEO
e-mail: [email protected]
Phone: +45 21 60 89 22

Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark

Sign up for press releases and receive relevant information about Allarity Therapeutics A/S